Sve / NYSE / HIMS.US

Hims & Hers Health

Hims & Hers Health

Investiraj bez provizije

Kupuj i prodaj dijelnice za samo 1 €

Informacije i statistika

Dnevni raspon
1D−100,00 %
3M−100,00 %
1T−100,00 %
6M−100,00 %
1M−100,00 %
1G−100,00 %
SIMBOL
HIMS
TRŽIŠTE
NYSE
ISIN
US4330001060

Datum

Zatvori

Promjena

Promjena (%)

Otvoreno

Visoko

Nisko

29,061,806,19 %27,2629,8527,11
27,510,582,11 %26,9328,0525,70
27,51−0,52−1,89 %28,0328,4127,02
27,761,585,69 %26,1828,2525,50
26,150,622,37 %25,5326,6524,12
25,380,542,13 %24,8425,9524,40
25,200,702,78 %24,5025,8024,21
23,85−0,03−0,13 %23,8824,7123,34
23,75−0,29−1,22 %24,0424,5423,27
24,011,184,91 %22,8324,0322,58
23,040,853,69 %22,1923,4221,85
22,440,291,29 %22,1522,7121,51
22,29−1,71−7,67 %24,0024,0022,12
25,051,355,39 %23,7025,3323,58
24,240,110,45 %24,1324,8123,36
24,14−0,35−1,45 %24,4924,9123,24
25,03−0,08−0,32 %25,1126,8724,54
29,140,160,55 %28,9830,4128,53
28,272,629,27 %25,6528,5425,38
25,65−1,09−4,25 %26,7427,1525,32
26,88−0,08−0,3 %26,9627,0825,77
26,33−0,54−2,05 %26,8726,8725,87
27,27−0,41−1,5 %27,6828,4326,64
27,410,180,66 %27,2327,8026,90
27,170,903,31 %26,2727,3525,59
26,33−1,18−4,48 %27,5127,6426,03
27,91−0,69−2,47 %28,6028,8327,63
29,39−0,52−1,77 %29,9130,7429,03
30,561,023,34 %29,5431,3328,89
28,15−1,97−7 %30,1231,4427,01
29,01−0,98−3,38 %29,9930,0328,03
29,761,183,97 %28,5830,8927,95
31,012,538,16 %28,4831,8828,40
28,821,164,02 %27,6629,7927,52
26,990,813 %26,1827,8124,74
24,292,6310,83 %21,6624,7221,26
21,36−0,39−1,83 %21,7521,9620,89
21,151,798,46 %19,3621,8219,31
19,43−0,51−2,62 %19,9420,1719,16
19,750,462,33 %19,2919,7918,95
19,39−1,42−7,32 %20,8120,9519,01
19,50−0,47−2,41 %19,9719,9718,94
20,330,552,71 %19,7820,3919,48
19,14−0,19−0,99 %19,3319,5218,73
19,84−1,13−5,7 %20,9721,6319,67
20,761,919,2 %18,8521,0218,61
18,78−0,52−2,77 %19,3019,6718,59
19,38−1,25−6,45 %20,6320,6319,16
20,860,291,39 %20,5721,2220,00
20,84−0,84−4,03 %21,6822,0020,54
21,34−0,80−3,75 %22,1422,3221,07
22,46−0,06−0,27 %22,5223,1022,22
22,02−1,91−8,67 %23,9324,2721,67
24,161,255,17 %22,9124,4122,59
23,15−1,68−7,26 %24,8325,0323,12
24,980,401,6 %24,5825,2623,97
24,880,672,69 %24,2125,1823,49
24,770,763,07 %24,0124,8423,22
23,84−3,10−13 %26,9426,9523,74
25,882,7510,63 %23,1327,5722,79
23,47−0,50−2,13 %23,9726,0222,42
22,16−1,08−4,87 %23,2423,3520,97
15,740,161,02 %15,5815,8615,19
15,88−0,68−4,28 %16,5616,8615,56
16,450,643,89 %15,8116,7615,78
15,82−0,26−1,64 %16,0816,9015,25
16,481,9611,89 %14,5216,5114,29
14,52−0,73−5,03 %15,2515,2914,45
15,60−0,16−1,03 %15,7616,3714,96
15,820,261,64 %15,5616,4815,05
15,460,674,33 %14,7916,0813,72
15,51−0,26−1,68 %15,7715,8015,13
15,63−0,04−0,26 %15,6716,3215,26
15,82−0,27−1,71 %16,0916,5615,45
15,84−0,20−1,26 %16,0416,4215,56
16,27−0,02−0,12 %16,2916,9315,77
16,300,160,98 %16,1416,8816,05
15,80−0,59−3,73 %16,3916,9815,60
16,69−0,79−4,73 %17,4817,6516,58
17,24−1,48−8,58 %18,7219,4117,17
19,331,527,86 %17,8119,5316,32
23,020,703,04 %22,3223,6421,13
23,48−3,15−13,42 %26,6327,8022,93
24,40−2,67−10,94 %27,0727,1123,97
25,54−1,00−3,92 %26,5426,8524,62
26,44−0,70−2,65 %27,1427,3726,40
27,09−2,31−8,53 %29,4030,2926,84
29,870,983,28 %28,8930,7228,43
28,67−1,27−4,43 %29,9429,9728,31
29,68−0,45−1,52 %30,1330,1928,90
30,280,612,01 %29,6730,9829,39
29,62−0,53−1,79 %30,1531,0029,37
30,521,073,51 %29,4530,7928,98
28,89−1,63−5,64 %30,5230,6627,93
30,470,341,12 %30,1331,3230,01
31,380,160,51 %31,2231,8330,61
31,23−0,37−1,18 %31,6031,6630,71
31,32−0,71−2,27 %32,0332,0530,74
32,20−0,98−3,04 %33,1833,2631,69
32,341,253,87 %31,0932,7829,89
31,69−2,60−8,2 %34,2934,3331,64
33,87−1,27−3,75 %35,1435,1433,48
35,46−0,03−0,08 %35,4936,4834,92
35,460,200,56 %35,2635,9634,30
34,710,742,13 %33,9735,7133,18
33,410,401,2 %33,0133,7632,04
32,47−0,38−1,17 %32,8532,9532,04
33,04−1,21−3,66 %34,2534,4133,01
34,100,110,32 %33,9934,7633,81
34,31−0,27−0,79 %34,5834,6233,48
34,670,050,14 %34,6235,0734,11
34,800,110,32 %34,6935,1734,09
35,05−0,90−2,57 %35,9536,2934,76
35,560,651,83 %34,9135,8834,60
34,77−0,87−2,5 %35,6436,0434,34
34,97−1,90−5,43 %36,8737,6334,86
36,861,012,74 %35,8536,9335,38
36,25−1,53−4,22 %37,7838,0335,66
37,21−0,43−1,16 %37,6438,9036,83
37,770,561,48 %37,2137,8836,62
37,88−1,81−4,78 %39,6939,8137,59
39,820,681,71 %39,1440,7538,90
39,12−0,23−0,59 %39,3539,6038,21
39,20−0,76−1,94 %39,9641,0139,18
40,021,724,3 %38,3040,4737,69
37,070,721,94 %36,3537,1535,77
36,31−1,28−3,53 %37,5938,2936,19
37,51−1,40−3,73 %38,9139,2637,44
39,760,842,11 %38,9239,8838,49
38,400,661,72 %37,7438,7937,34
37,09−0,85−2,29 %37,9438,3836,87
37,782,646,99 %35,1438,1635,03
34,711,123,23 %33,5935,0132,88
33,62−3,38−10,05 %37,0037,2333,44
35,83−0,74−2,07 %36,5736,5934,40
36,260,531,46 %35,7336,7534,10
35,58−1,05−2,95 %36,6337,6633,88
36,981,554,19 %35,4338,1034,91
36,05−2,80−7,77 %38,8538,9835,77
39,02−0,56−1,44 %39,5840,2738,23
39,75−1,02−2,57 %40,7741,2738,84
41,05−1,53−3,73 %42,5842,6840,20
41,030,300,73 %40,7341,2839,35
41,52−2,33−5,61 %43,8543,8539,83
43,73−0,36−0,82 %44,0946,7843,65
42,79−2,97−6,94 %45,7648,3542,39
44,39−2,38−5,36 %46,7747,1043,98
45,460,290,64 %45,1747,2745,02
44,06−1,89−4,29 %45,9546,9244,02
46,63−0,43−0,92 %47,0648,4746,03
47,12−1,85−3,93 %48,9749,1847,12
48,23−1,90−3,94 %50,1350,2248,13
48,78−1,25−2,56 %50,0351,0048,73
48,490,561,15 %47,9348,6246,86
47,46−1,39−2,93 %48,8548,8946,12
49,36−1,54−3,12 %50,9051,3849,29
51,360,030,06 %51,3352,4350,20
49,78−7,32−14,7 %57,1057,3849,64
59,15−2,95−4,99 %62,1063,6557,79
62,767,4011,79 %55,3665,3154,40
54,020,831,54 %53,1955,1551,74
54,730,320,58 %54,4156,2953,82
53,95−4,29−7,95 %58,2459,2353,00
58,25−0,84−1,44 %59,0960,0156,25
58,17−0,33−0,57 %58,5060,1657,01
57,973,195,5 %54,7858,2654,48
54,761,152,1 %53,6154,8052,68
52,54−5,43−10,33 %57,9758,9352,49
57,870,891,54 %56,9859,3056,75
56,310,410,73 %55,9057,6355,08
56,72−1,67−2,94 %58,3959,1955,77
59,120,490,83 %58,6360,5758,24
58,403,826,54 %54,5858,4254,10
54,872,825,14 %52,0555,1250,69
53,25−3,23−6,07 %56,4856,7553,00
56,00−1,12−2 %57,1257,7555,28
57,70−0,42−0,73 %58,1258,9556,40
57,821,602,77 %56,2259,3856,14
56,205,7710,27 %50,4356,3350,28
50,350,160,32 %50,1951,0149,14
50,89−3,43−6,74 %54,3254,3248,77
53,96−0,86−1,59 %54,8256,5453,88
55,504,478,05 %51,0355,9650,22
51,762,955,7 %48,8152,5148,59
47,78−2,15−4,5 %49,9351,4447,49
47,79−2,27−4,75 %50,0650,3947,45
49,640,501,01 %49,1451,6049,07
48,41−0,41−0,85 %48,8249,1846,83
48,113,637,55 %44,4848,3144,29
44,461,533,44 %42,9345,6942,51
41,530,000 %41,5342,1740,75
42,35−1,82−4,3 %44,1744,4842,22
44,12−0,36−0,82 %44,4845,1243,81
44,01−1,23−2,79 %45,2445,9543,97
45,351,673,68 %43,6845,6143,08
42,99−1,43−3,33 %44,4244,8542,94
44,571,643,68 %42,9345,7242,62
43,960,611,39 %43,3544,9542,95
43,380,892,05 %42,4943,6840,94
42,18−2,60−6,16 %44,7845,1241,90
45,10−0,18−0,4 %45,2845,7844,54
46,02−0,04−0,09 %46,0647,3645,35
47,13−0,23−0,49 %47,3647,8345,27
48,33−0,11−0,23 %48,4448,6346,75
47,96−0,75−1,56 %48,7148,9947,23
49,98−1,48−2,96 %51,4652,0649,53
51,94−0,14−0,27 %52,0852,6950,40
51,05−0,62−1,21 %51,6753,5650,22
51,13−4,51−8,82 %55,6455,7150,20
55,520,240,43 %55,2864,1354,75
63,35−0,44−0,69 %63,7965,5662,29
62,55−2,00−3,2 %64,5566,1961,67
66,18−0,02−0,03 %66,2070,4665,86
65,534,947,54 %60,5966,4560,59
60,272,644,38 %57,6360,8756,07
58,68−0,06−0,1 %58,7459,8556,51
57,65−0,48−0,83 %58,1359,9654,34
57,32−0,18−0,31 %57,5057,9055,57
58,028,1414,03 %49,8859,1749,78
50,012,074,14 %47,9450,6146,93
47,60−2,62−5,5 %50,2250,3347,52
50,38−0,27−0,54 %50,6551,0948,49
49,99−1,78−3,56 %51,7752,0549,65
51,850,971,87 %50,8852,1949,37
50,46−2,54−5,03 %53,0053,0050,18
52,034,348,34 %47,6952,3247,43
47,89−2,16−4,51 %50,0550,7747,74
50,27−1,30−2,59 %51,5751,9049,99
51,240,731,42 %50,5152,3648,65
48,96−0,02−0,04 %48,9850,8348,28
48,421,412,91 %47,0148,5045,03
47,980,400,83 %47,5849,0846,57
47,46−0,74−1,56 %48,2048,2046,69
47,96−0,87−1,81 %48,8350,9146,99
49,85−0,69−1,38 %50,5450,7648,31
49,412,454,96 %46,9651,9946,37
46,284,559,83 %41,7346,8240,89
41,41−2,15−5,19 %43,5646,5241,19
42,950,521,21 %42,4344,4141,81
41,98−6,23−14,84 %48,2148,3841,94
64,221,342,09 %62,8864,6161,51
61,070,480,79 %60,5962,5258,16
59,24−0,44−0,74 %59,6860,4656,60
59,782,964,95 %56,8261,6755,74
55,480,090,16 %55,3957,6054,65
57,150,841,47 %56,3159,9256,18
57,562,905,04 %54,6657,7553,62
55,25−1,60−2,9 %56,8558,7753,54
56,86−0,34−0,6 %57,2057,2254,58
56,333,175,63 %53,1657,5252,74
52,77−1,12−2,12 %53,8954,8451,82
53,61−2,10−3,92 %55,7159,3152,77
54,73−7,17−13,1 %61,9067,3654,25
56,77−0,06−0,11 %56,8358,7855,65
56,564,087,21 %52,4857,4052,08
52,40−1,57−3 %53,9755,0252,09
53,34−0,53−0,99 %53,8754,1251,39
53,36−2,72−5,1 %56,0856,3252,81
54,831,312,39 %53,5255,3852,86
53,52−0,01−0,02 %53,5356,5251,17
58,00−2,23−3,84 %60,2363,2057,63
61,21−1,40−2,29 %62,6163,6859,78
62,34−0,35−0,56 %62,6963,6361,13
64,655,268,14 %59,3964,8257,40
58,58−1,81−3,09 %60,3962,7053,69
61,12−3,12−5,1 %64,2465,8760,80
64,007,8612,28 %56,1464,1755,94
55,21−1,10−1,99 %56,3158,6154,19
51,962,544,89 %49,4252,2348,85
51,40−0,13−0,25 %51,5354,7650,01
52,354,478,54 %47,8852,3847,18
49,4711,1922,62 %38,2850,5638,24
41,88−0,35−0,84 %42,2343,0439,82
40,823,909,55 %36,9241,1136,59
36,162,446,75 %33,7236,7032,02
33,10−0,63−1,9 %33,7333,8931,75
35,04−2,81−8,02 %37,8537,8532,96
28,48−1,36−4,78 %29,8430,8827,67
28,090,411,46 %27,6828,3026,99
28,141,083,84 %27,0628,7726,87
26,71−0,29−1,09 %27,0028,5826,39
25,35−1,14−4,5 %26,4926,7225,12
25,84−0,80−3,1 %26,6426,9525,23
27,232,117,75 %25,1227,4525,12
26,95−1,67−6,2 %28,6228,7326,19
29,460,933,16 %28,5329,8728,12
28,31−0,30−1,06 %28,6129,0227,18
27,230,491,8 %26,7427,3625,70
26,81−1,63−6,08 %28,4428,8825,99
29,493,2110,89 %26,2830,3025,42
26,10−3,51−13,45 %29,6129,8025,13
27,773,2911,85 %24,4829,6723,98
25,99−0,35−1,35 %26,3427,0723,94
27,99−0,20−0,71 %28,1929,9027,78
31,221,906,09 %29,3231,2828,98
31,051,434,61 %29,6233,7128,73
29,551,936,53 %27,6230,2027,21
29,14−2,54−8,72 %31,6831,9128,88
31,92−1,04−3,26 %32,9633,3231,78
33,36−4,56−13,67 %37,9237,9233,22
37,04−0,93−2,51 %37,9738,7135,75
37,411,293,45 %36,1238,2034,91
34,752,406,91 %32,3535,2031,89
32,87−0,31−0,94 %33,1834,2632,34
33,882,156,35 %31,7334,9631,03
31,49−2,64−8,38 %34,1334,4131,24
34,691,093,14 %33,6035,7132,60
33,141,063,2 %32,0833,3131,51
31,54−1,69−5,36 %33,2333,6630,98
33,93−2,38−7,01 %36,3137,2532,75
34,71−0,07−0,2 %34,7837,7234,28
34,470,200,58 %34,2737,1733,33
35,951,554,31 %34,4036,2832,66
34,39−2,83−8,23 %37,2238,7133,97
40,893,127,63 %37,7741,3437,40
40,492,355,8 %38,1442,2236,79
40,68−4,30−10,57 %44,9846,3739,67
45,094,9410,96 %40,1545,3240,15
41,34−1,89−4,57 %43,2345,8140,43
41,891,673,99 %40,2244,6539,90
39,86−0,10−0,25 %39,9643,2336,01
51,313,216,26 %48,1052,7043,80
49,28−4,26−8,64 %53,5457,3949,02
66,411,382,08 %65,0367,3859,59
68,7410,0714,65 %58,6773,0058,67
58,50−2,21−3,78 %60,7160,9756,41
60,470,440,73 %60,0364,8658,61
59,1811,6619,7 %47,5259,5847,11
46,343,267,03 %43,0846,5142,82
43,58−0,62−1,42 %44,2045,1542,70
44,771,493,33 %43,2845,1841,29
42,551,072,51 %41,4846,0041,48
40,47−1,42−3,51 %41,8943,1739,24
42,200,230,55 %41,9744,4441,38
41,852,516 %39,3442,0138,37
38,933,9410,12 %34,9939,7534,99
37,283,469,28 %33,8237,9733,71
33,961,825,36 %32,1434,3632,12
31,86−0,04−0,13 %31,9032,3230,89
31,540,351,11 %31,1932,7630,33
30,511,254,1 %29,2631,8829,09
30,87−0,07−0,23 %30,9432,0830,62
30,891,775,73 %29,1230,9328,49
29,720,200,67 %29,5230,2128,73
29,811,063,56 %28,7530,0228,00
27,850,180,65 %27,6728,0925,55
27,94−0,14−0,5 %28,0828,7026,66
27,860,622,23 %27,2427,9825,91
26,210,341,3 %25,8726,6125,15
25,901,194,59 %24,7126,4024,19
25,411,244,88 %24,1725,6024,09
25,73−0,94−3,65 %26,6728,3125,46
27,670,000 %27,6728,8426,24
26,90−0,44−1,64 %27,3428,2026,35
26,631,455,44 %25,1826,7725,05
25,200,592,34 %24,6125,8824,17
24,18−1,40−5,79 %25,5825,7324,10
25,17−0,38−1,51 %25,5526,1524,98
26,56−1,87−7,04 %28,4328,6326,37
28,490,461,61 %28,0330,2427,74
28,150,180,64 %27,9728,3227,35
27,600,692,5 %26,9127,7126,18
26,200,200,76 %26,0027,1625,30
26,360,672,54 %25,6927,8124,60
28,55−2,86−10,02 %31,4131,6428,18

Povezane rasprave

Yoosuf

prije 5 sati

BOOM

BOOM

Thomasvhoorn

jučer

Hims house Update

HIGHLIGHTS Hims AND Hers both hit all-time-high weekly web traffic in the same week (week ending May 17) 🤯 Hims has reclaimed the web traffic lead from Ro, and is now growing faster y/y (+27% vs +19%) Hers iOS app just posted its best-ever weekly rank in the app store (#11) 🔥 Hers continues to outrank Hims, full stop -- ahead on both the latest week (#11 vs #19) and the 30-day average (#13 vs #21) Every telehealth app we track climbed this week: Hims, Hers, Ro, and One Medical all improved, and even cellar-dweller LifeMD bounced 30 spots (#195 → #165) though still >100 spots below the rest Y/y sales now positive 3 of the last 4 weeks. Paired with the strong web traffic + app rankings, it looks like the long-awaited “reacceleration” might finally be here Hims Meta ads pivoted hard back to !@#$; Hers is leaning into weight loss (now well over half its ads)

aliedrees

prekjučer

Back to $50 is prolly nearing

Back to $50 is prolly nearing

Yoosuf

prekjučer

Hims is a flop

“ Hims is a flop” “ Hims is going back to 16” is what everyone was saying a month ago and while it was taking a beating. Happy to see that the company has proved them wrong. Continuous growth and continuous development since then. Props to all those that didn’t sell and held conviction!

shakjaf110

prije 6 dana

Finally green again

Was disappointed by earning result, this stock have huge potential yet very undervalued.

Yoosuf

prošli tjedan

Finally green

Finally green

MissMomentum

prije 2 tjedna

News: Hims & Hers launches generics for Novo’s semaglutide in Canada

News: Hims & Hers launches generics for Novo’s semaglutide in Canada

Corgen

prije 2 tjedna

Bad news and PERCIEVED bad news

So I have been trying to answer the question: What are the real bad news and what are just "feels bad" news The bad thing is that the "feel bad" will win in short term and do fine in long term provided that good news follow. The problem now is that all these recent news kinda throw Hims into a stagnation / falling price action. That fact will feed itself back and it will not fly up unless some really good news come which I don't see will happen for a while. Short term bad news will move the price fast. The long-term proposition is now little less sure in my eyes because any more bad news now will send the stock into free fall. As this is only a 10% of my portfolio, I will be leaving this stock as it is and not add more. Will see what happens for the next 3 months before another earnings report. If price should start recovering, I will return to this and start thinking about buying more. I am just not certain atm about short term price movements. Any well reasoned prognoses from long-term investors in here?

Vivaciiyo

prije 2 tjedna

Offering

Hims announces proposed convertible senior notes offering

Lucifersadviser

prije 2 tjedna

Convertible stocks - opinion

As much as I like HIMS, this is such a bad management move. The convertible loans will dilute share holders and share earnings. Furthermore, they previously said they would fund the eucalyptus acquisition through a strong cash balance. So are we just going to pretend they didn’t change their narrative? This company went from 0 debt and a good cash flow to now expanding rapidly whilst margins have depleted and other players are aggressively entering the space. If they had the same organic growth they had a year ago, this expansion would be justified. But the board of members are selling their shares and now deciding to spend 300 million diluting share holders whilst they spent more on buy backs at twice the current price. Management is absolutely terrible. They need to spend on better social media marketing and a better user experience because the website sucks (doesn’t allow you to browse products and instantly wants all your details before you can even check what the products are) and so does their social media platforms, sterile and always the same vague basic posts. They’re just spending on irrelevant things it seems.

Corgen

prije 3 tjedna

Earnings - my first digestion stage

After digesting the earnings After seeing the whole market drop today and Hims pretty much flat... I am beginning to feel more secure in the mid to long-term. Was aiming to add at $24 after earnings and it hasn't fallen there again yet. Started acquiring 3x longs which fell 48% and I managed to but at -40% so I am 8% down. Will be adding on previous dip points. Always keeping enough cash to buy and average down massively if "tihs" (read bcckwards) hits the fan. Keeping my position at 10% so the 90% can very well average down my long position in the worst case scenario. This way my gains if price recovers are starting at 10% but I can add on the way up as well so effectively keeping my long in safety. Not gonna try to buy with 100% and hope to hit the bottom. Never works.

Na ovoj se stranici možda nalazi sadržaj koji je izradila zajednica za koji platforma Trading 212 nije odgovorna. Uvijek sami provjerite sve informacije. Trading 212 pruža samo uslugu izvršenja i ne nudi investicijske savjete ili upravljanje portfeljem.

Ulaganje bez provizije za sve

Kupuj i prodaj Hims & Hers Health Inc +1,47 $ (5,34 %) i više od 13.000 globalnih dionica i ETF-ova

Možda se primjenjuju druge naknade. Pogledaj naše uvjete i naknade.

Pogledaj naše uvjete i naknade ovdje

phone

Odmah kupi dionice

Odaberi svoju omiljenu tvrtku

Odluči koliko želiš uložiti

Preuzmi dionice za nekoliko sekundi

Izgradnja bogatstva je navika.
Automatiziraj je pomoću pie.

Uloži u gotove pies ili stvori vlastite odabirom među tisućama dionica i ETF-ova

Saznaj više

Saznaj više

Pogledaj video

Kupi čak i najskuplje dionice kao što su Google, Amazon i Apple

Pogledaj video

Prikaži sve instrumente trgovanja

Podrška 24/7

Prosječno vrijeme odgovora iznosi 29 sekundi

Počni graditi svoje bogatstvo sada

Pridruži se zajednici od 5 milijuna korisnika

Preuzmi aplikaciju

Otvori račun

Preuzmi mobilnu aplikaciju

qr-code

Svi prikazani statistički podaci su globalni. Broj klijenata predstavlja financirane račune.

Izvrsno

Ocjena 4,6 / 5 na osnovi 93.595 recenzije/a s platforme

Trustpilot

Ocjena 4,6 / 5 na osnovi 93.595 recenzije/a s platforme

Trustpilot

Pozvan

Great

Immediate updates, easy to use and manage.

Pozvan

Very easy to use

Very easy to use. Intuitive app and makes it straight forward to sit back and let your investment's do its work

Pozvan

Ease of use

Easy to set up an account Easy to transfer funds Great interest rate Great all round experience

Pozvan

Easy to set up my account

Easy to set up my account easy to access balance and a very good rate in interest.

Pozvan

easy to use platform

easy to use platform, love the ability to transfer cash isa funds into stocks and shares isa

Pozvan

Simple and Informative platform

I wanted a platform which was offering great rates for my ISA, but discovered not only did this platform do that. It also gave me an insight into trading and world markets. It's quite simply brilliant.

Pozvan

Great app that provides all my account…

Great app that provides all my account info at my fingertips

Pozvan

Easy to use.

Easy to use. Can view everything simply. Just what I need.

Pozvan

Good interest rate and can take the…

Good interest rate and can take the money out whenever I want.

Pozvan

So easy

So easy! Makes investing a pleasure

Pozvan

I’m novice and useless with technology…

I’m novice and useless with technology but I found this an easy site to navigate and to deal with.

Pozvan

Nice app

Great app, very intuitive and simple to use. Gold standard.

Pozvan

Very easy to use

Very easy to use. Very clear. And a joy to watch my savings rise

Pozvan

Easy to use

Functional and easy to use and track my cash & stocks & shares isas

Pozvan

Easy access to my account and how Easy…

Easy access to my account and how Easy it is to navigate the212 application.

Pozvan

Simple and easy to use app

Simple and easy to use app. Ease of setting up recurring payments. Great for a beginner that has no prior knowledge or experience of investing.

Pozvan

Easy and simple app

Easy and simple app, tells you daily your interest which I like and I get emails. The updating is really good.

Pozvan

Very easy and highly recommend

Very easy and highly recommend. Straight forward to use and cost instructions on the fees and charges.

Pozvan

Great way for your money to build

Just very pleased with the level of savings rate and steady build up.

Pozvan

Cool app

User friendly mobile app that makes investing easy and funny. Fast navigation throughout the app. In a few clicks can see basically every information one might require.

Prikazuju se neke od pozitivnih recenzija naših klijenata

Naše nagrade

Česta pitanja

Koja je cijena dionice Hims & Hers Health (HIMS)?

Trenutna cijena Hims & Hers Health (HIMS) je 28,98 $.

Koji je 52-tjedni maksimum za HIMS?

52-tjedni maksimum za HIMS je 70,46 $.

Koji je 52-tjedni minimum za HIMS?

52-tjedni minimum za HIMS je 13,72 $.

Kakva je tjedna učinkovitost HIMS?

U proteklom tjednu cijena HIMS promijenila se za 14,18 %.

Kakva je mjesečna učinkovitost HIMS?

Tijekom proteklog mjeseca, cijena HIMS promijenila se za 5,73 %.

Kakva je 3-mjesečna performansa HIMS?

U posljednja tri mjeseca cijena HIMS promijenila se za 83,19 %.

Kakva je 6-mjesečna performansa HIMS?

U posljednjih šest mjeseci cijena HIMS promijenila se za −21,82 %.

Kakva je godišnja učinkovitost HIMS?

Tijekom protekle godine cijena HIMS promijenila se za −47,05 %.